Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 426

1.

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, Furlan M, Lämmle B, Wuillemin WA.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1020-5.

3.
4.

Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.

Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, Dardik R, Baron Z, Seligsohn U.

Blood. 1999 Apr 1;93(7):2186-90.

5.

The factor II G20210A and factor V G1691A gene transitions and coronary heart disease.

Gardemann A, Arsic T, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W.

Thromb Haemost. 1999 Feb;81(2):208-13.

PMID:
10063993
6.

Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease.

Dunn ST, Roberts CR, Schechter E, Moore WE, Lee ET, Eichner JE.

Thromb Res. 1998 Jul 15;91(2):91-9.

PMID:
9722025
7.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

8.

Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction.

Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, Rosendaal FR.

Br J Haematol. 2003 Aug;122(3):471-8.

PMID:
12877676
9.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
10.

Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.

Eterović D, Titlić M, Culić V, Zadro R, Primorac D.

Clin Appl Thromb Hemost. 2007 Apr;13(2):188-93.

PMID:
17456629
11.
12.

Thrombophilia in young patients with acute myocardial infarction.

Celik M, Altintas A, Celik Y, Karabulut A, Ayyildiz O.

Saudi Med J. 2008 Jan;29(1):48-54.

PMID:
18176672
13.

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR.

Blood. 2000 Oct 1;96(7):2364-8.

14.

Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.

Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):36-40.

PMID:
10726047
15.
16.

Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH.

Blood. 1997 Apr 15;89(8):2817-21.

17.

[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].

Reitsma PH, van de Stolpe A.

Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5. Review. Dutch.

PMID:
11593787
18.
19.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.

Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM.

J Thromb Haemost. 2006 Dec;4(12):2582-6. Epub 2006 Sep 15.

20.
Items per page

Supplemental Content

Write to the Help Desk